CIMAX
Price
$26.80
Change
+$0.09 (+0.34%)
Updated
Jul 3 closing price
Net Assets
135.1B
HRLCX
Price
$9.05
Change
-$0.01 (-0.11%)
Updated
Jul 3 closing price
Net Assets
61.7M
Interact to see
Advertisement

CIMAX vs HRLCX

Header iconCIMAX vs HRLCX Comparison
Open Charts CIMAX vs HRLCXBanner chart's image
American Funds Income Fund of Amer 529A
Price$26.80
Change+$0.09 (+0.34%)
VolumeN/A
Net Assets135.1B
Hartford Real Asset C
Price$9.05
Change-$0.01 (-0.11%)
VolumeN/A
Net Assets61.7M
CIMAX vs HRLCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CIMAX vs. HRLCX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMAX is a Buy and HRLCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMAX has more cash in the bank: 135B vs. HRLCX (61.7M). CIMAX pays higher dividends than HRLCX: CIMAX (3.66) vs HRLCX (2.64). CIMAX was incepted earlier than HRLCX: CIMAX (23 years) vs HRLCX (15 years). HRLCX (2.33) is less costly to investors than CIMAX (0.61). HRLCX is a more actively managed with annual turnover of: 198.00 vs. CIMAX (92.00). CIMAX has a lower initial minimum investment than HRLCX: CIMAX (250) vs HRLCX (2000). CIMAX annual gain was more profitable for investors over the last year : 15.20 vs. HRLCX (7.98). HRLCX (50.74) and CIMAX (50.07) have equivalent 5 years return.
CIMAXHRLCXCIMAX / HRLCX
Total Expense Ratio0.612.0130%
Annual Report Gross Expense Ratio0.612.3326%
Fund Existence23 years15 years-
Gain YTD11.50613.10988%
Front Load4%N/A-
Min. Initial Investment250200013%
Min. Initial Investment IRAN/AN/A-
Net Assets135B61.7M218,801%
Annual Yield % from dividends3.662.64139%
Returns for 1 year15.207.98191%
Returns for 3 years28.8221.91132%
Returns for 5 years50.0750.7499%
Returns for 10 years74.8040.05187%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMECF365.9812.93
+3.66%
SMC Corp
BFNH0.420.01
+2.42%
BioForce Nanosciences Holdings, Inc.
GGDVF0.81N/A
N/A
Guangdong Investment Ltd.
HISJF13.09N/A
N/A
H I S Co., Ltd.
GENFF0.01N/A
N/A
Genflow Biosciences Plc